Immunotherapies in rare cancers

Cancer remains a leading cause of death worldwide, placing a significant burden on healthcare systems as well as the global economy. Rare cancers comprise a group of about 200 cancers that individually occur at extremely low frequencies. In the United States (US), their frequency is approximately 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivekanandhan, Sneha, Bahr, Deborah, Kothari, Ashish, Ashary, Mohammed Ali, Baksh, Mizba, Gabriel, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890725/
https://www.ncbi.nlm.nih.gov/pubmed/36726126
http://dx.doi.org/10.1186/s12943-023-01720-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890725/
https://www.ncbi.nlm.nih.gov/pubmed/36726126
http://dx.doi.org/10.1186/s12943-023-01720-2

Ejemplares similares